These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
527 related articles for article (PubMed ID: 31600142)
1. LncRNA TTN-AS1 regulates osteosarcoma cell apoptosis and drug resistance via the miR-134-5p/MBTD1 axis. Fu D; Lu C; Qu X; Li P; Chen K; Shan L; Zhu X Aging (Albany NY); 2019 Oct; 11(19):8374-8385. PubMed ID: 31600142 [TBL] [Abstract][Full Text] [Related]
2. Long non-coding RNA TTN-AS1 promotes cell proliferation and inhibits cell apoptosis in prostatic cancer by sponging miR-193a-5p. Luo JF; Xu J; Zheng JZ Eur Rev Med Pharmacol Sci; 2019 Sep; 23(18):7816-7825. PubMed ID: 31599406 [TBL] [Abstract][Full Text] [Related]
3. LncRNA TTN-AS1/miR-134-5p/PAK3 axis regulates the radiosensitivity of human large intestine cancer cells through the P21 pathway and AKT/GSK-3β/β-catenin pathway. Zuo Z; Ji S; He L; Zhang Y; Peng Z; Han J Cell Biol Int; 2020 Nov; 44(11):2284-2292. PubMed ID: 32749739 [TBL] [Abstract][Full Text] [Related]
4. LncRNA LOXL1-AS1/miR-let-7a-5p/EGFR-related pathway regulates the doxorubicin resistance of prostate cancer DU-145 cells. Bai T; Liu Y; Li B IUBMB Life; 2019 Oct; 71(10):1537-1551. PubMed ID: 31188543 [TBL] [Abstract][Full Text] [Related]
5. LncRNA TTN-AS1 acts as sponge for miR-15b-5p to regulate FBXW7 expression in ovarian cancer. Miao S; Wang J; Xuan L; Liu X Biofactors; 2020 Jul; 46(4):600-607. PubMed ID: 32049388 [TBL] [Abstract][Full Text] [Related]
6. LncRNA TTN-AS1 intensifies sorafenib resistance in hepatocellular carcinoma by sponging miR-16-5p and upregulation of cyclin E1. Zhou Y; Huang Y; Dai T; Hua Z; Xu J; Lin Y; Han L; Yue X; Ho L; Lu J; Ai X Biomed Pharmacother; 2021 Jan; 133():111030. PubMed ID: 33378944 [TBL] [Abstract][Full Text] [Related]
7. LncRNA FOXD2-AS1 knockdown inhibits the resistance of human osteosarcoma cells to cisplatin by inhibiting miR-143 expression. Zhang QQ; Xu SL; Ding C; Ma CC; Yuan TS; Hua CC; Wang XH Eur Rev Med Pharmacol Sci; 2021 Jan; 25(2):678-686. PubMed ID: 33577022 [TBL] [Abstract][Full Text] [Related]
8. Long noncoding RNA OIP5-AS1 causes cisplatin resistance in osteosarcoma through inducing the LPAATβ/PI3K/AKT/mTOR signaling pathway by sponging the miR-340-5p. Song L; Zhou Z; Gan Y; Li P; Xu Y; Zhang Z; Luo F; Xu J; Zhou Q; Dai F J Cell Biochem; 2019 Jun; 120(6):9656-9666. PubMed ID: 30548308 [TBL] [Abstract][Full Text] [Related]
9. Long noncoding RNA Li S; Liu F; Pei Y; Wang W; Zheng K; Zhang X Aging (Albany NY); 2019 Sep; 11(18):7678-7693. PubMed ID: 31525734 [TBL] [Abstract][Full Text] [Related]
10. LncRNA TTN-AS1 sponges miR-376a-3p to promote colorectal cancer progression via upregulating KLF15. Wang Y; Jiang F; Xiong Y; Cheng X; Qiu Z; Song R Life Sci; 2020 Mar; 244():116936. PubMed ID: 31610194 [TBL] [Abstract][Full Text] [Related]
11. Long non-coding RNA titin-antisense RNA1 contributes to growth and metastasis of cholangiocarcinoma by suppressing microRNA-513a-5p to upregulate stratifin. Liu Y; Sun J; Qi P; Liu Y Bioengineered; 2021 Dec; 12(2):12611-12624. PubMed ID: 34903127 [TBL] [Abstract][Full Text] [Related]
12. LncRNA TTN-AS1 promotes migration, invasion, and epithelial mesenchymal transition of lung adenocarcinoma via sponging miR-142-5p to regulate CDK5. Jia Y; Duan Y; Liu T; Wang X; Lv W; Wang M; Wang J; Liu L Cell Death Dis; 2019 Jul; 10(8):573. PubMed ID: 31363080 [TBL] [Abstract][Full Text] [Related]
13. The role and clinical significance of long noncoding RNA zinc finger E-box-binding homeobox two antisense RNA 1 in promoting osteosarcoma cancer cell proliferation, inhibiting apoptosis and increasing migration by regulating miR-145. Zhou Y; Feng D; Gu X; Gao A; Liu Y Anticancer Drugs; 2021 Feb; 32(2):168-177. PubMed ID: 32826416 [TBL] [Abstract][Full Text] [Related]
14. Inhibition of LncRNA FOXD3-AS1 suppresses the aggressive biological behaviors of thyroid cancer via elevating miR-296-5p and inactivating TGF-β1/Smads signaling pathway. Chen Y; Gao H; Li Y Mol Cell Endocrinol; 2020 Jan; 500():110634. PubMed ID: 31678422 [TBL] [Abstract][Full Text] [Related]
15. A novel lncRNA MCM3AP-AS1 promotes the growth of hepatocellular carcinoma by targeting miR-194-5p/FOXA1 axis. Wang Y; Yang L; Chen T; Liu X; Guo Y; Zhu Q; Tong X; Yang W; Xu Q; Huang D; Tu K Mol Cancer; 2019 Feb; 18(1):28. PubMed ID: 30782188 [TBL] [Abstract][Full Text] [Related]
16. Silencing lncRNA FOXD2-AS1 inhibits proliferation, migration, invasion and drug resistance of drug-resistant glioma cells and promotes their apoptosis via microRNA-98-5p/CPEB4 axis. Gu N; Wang X; Di Z; Xiong J; Ma Y; Yan Y; Qian Y; Zhang Q; Yu J Aging (Albany NY); 2019 Nov; 11(22):10266-10283. PubMed ID: 31770107 [TBL] [Abstract][Full Text] [Related]
17. Downregulated Long Non-Coding RNA MSC-AS1 Inhibits Osteosarcoma Progression and Increases Sensitivity to Cisplatin by Binding to MicroRNA-142. Zhang L; Zhao G; Ji S; Yuan Q; Zhou H Med Sci Monit; 2020 Mar; 26():e921594. PubMed ID: 32155139 [TBL] [Abstract][Full Text] [Related]
18. LncRNA PRKCQ-AS1 regulates paclitaxel resistance in triple-negative breast cancer cells through miR-361-5p/PIK3C3 mediated autophagy. Zheng S; Fu W; Huang Q; Zhou J; Lu K; Gu J; Ma R; Guo G Clin Exp Pharmacol Physiol; 2023 Jun; 50(6):431-442. PubMed ID: 36732923 [TBL] [Abstract][Full Text] [Related]
19. [LncRNA LINC-PINT regulating proliferation and apoptosis of osteosarcoma cells by targeting miR-524-5p]. Yang H; Cao C; Wang LJ Zhonghua Zhong Liu Za Zhi; 2020 Apr; 42(4):325-330. PubMed ID: 32375449 [No Abstract] [Full Text] [Related]
20. LncRNA TMPO-AS1 serves as a ceRNA to promote osteosarcoma tumorigenesis by regulating miR-199a-5p/WNT7B axis. Cui H; Zhao J J Cell Biochem; 2020 Mar; 121(3):2284-2293. PubMed ID: 31680323 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]